The completion and smooth relocation of the new Hebei Yanda Ludaopei Hospital campus mark a major step forward for the Ludaopei Medical Group’s clinical capacity. On this occasion, internationally renowned hematologist Professor Robert Negrin—Director of the Blood and Marrow Transplantation Program at Stanford University and President-Elect of the American Society of Hematology (ASH)—visited the hospital for an in-depth exchange with Professor Lu Peihua, who leads the Ludaopei Medical Group. Their discussion centered on the evolution of cellular therapies, clinical challenges in CAR-T, and opportunities for global collaboration. Both sides emphasized that cross-border cooperation and open academic exchange are essential engines driving progress in hematologic disease care. Oncology Frontier – Hematology Frontier presents key takeaways from this Sino-U.S. dialogue to offer both practical reference and insight for the cell therapy community.
